Experts panel on the future use of Titanium Dioxide (E171) in Pharma

If you want to learn more about the FACTS related to the recent ban of TiO2 (E171) in Europe for food uses and the potential impact this could have globally on pharmaceuticals, I suggest that you check out this Expert Panel Discussion that I participated in along with several other experts in the area. Please remember that there have been NO scientifically credible safety concerns demonstrated with the use of TiO2 in foods or pharmaceuticals. Simply a few data gaps which will be addressed by industry in the near future.

This discussion covers many of the key topics related to the current regulatory situation in the EU and the significant technical and patient availability challenges that would exist if this ban were to be extended to pharmaceuticals.

You can hear the first 10 minutes of the panel discussion at the link below and this will then give you access to the full panel discussion (about 60 minutes) if you simply provide your name and email address.

Experts panel on the future use of Titanium Dioxide (E171) in Pharma - Pharma Excipients